5:53 PM ET
Form 4
Insider Selling
Mineralys Therapeutics CEO Jon Congleton Sells $1.91M of Stock
Jon Congleton, CEO, sold 75,000 shares of Mineralys Therapeutics, Inc. at $25.46 a share, worth $1.91M in total on Sep 30, 2026. Shares held after the trade: 528,621 (-12.4%).
- Value
- $1.91M
- Shares
- 75,000
- Price
- $25.46
- Role
- CEO
- Holding change
- -12.4%
- Trade date
- Sep 30, 2026